activated charcoal tablets
irbitskiy himfarmzavod jsc - activated charcoal - tablets - 250mg
vaxigrip tetra suspension for injection / quadrivalent influenza vaccine (split virion, inactivated)
sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg a/thailand/8/2022 (h3n2)-like strain (a/california/122/2022, san-022) 15 µg b/austria/1359417/2021-like strain (b/michigan/01/2021, wild type) 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) 15 µg - vaccines
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,
inactivated infectious bursal disease virus (strain ibdv d78)
intervet australia pty limited - inactivated infectious bursal disease virus (strain d78) - unknown - inactivated infectious bursal disease virus (strain d78) vaccine-viral active 0.0 - active constituent
inactivated rabbit calicivirus disease virus
zoetis australia pty ltd - inactivated rabbit calicivirus disease virus - unknown - inactivated rabbit calicivirus disease virus vaccine-viral active 0.0 - active constituent
inactivated newcastle disease virus antigen
zoetis australia pty ltd - inactivated newcastle disease virus antigen - unknown - inactivated newcastle disease virus antigen vaccine-viral active 0.0 - active constituent
inactivated propionibacterium acnes
virbac (australia) pty ltd - inactivated propionibacterium acnes - unknown - inactivated propionibacterium acnes vaccine-microbial active 0.0 - active constituent
carbosorb xs activated charcoal 50 g/250 ml and sorbitol 70.75 g/250 ml suspension bottle
phebra pty ltd - activated charcoal, quantity: 0.2 g/ml; sorbitol, quantity: 0.283 g/ml - suspension - excipient ingredients: propylene glycol; citric acid; sodium hydroxide; glycerol; purified water - for the treatment of poisoning and drug overdosage by oral ingestion.
ipol (poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus
a-s medication solutions - poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - ipol vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus types 1, 2, and 3. (28) it is recommended that all infants (as young as 6 weeks of age), unimmunized children, and adolescents not previously immunized be vaccinated routinely against paralytic poliomyelitis. (29) following the eradication of poliomyelitis caused by wild poliovirus from the western hemisphere (including north and south america) (30), an ipv-only schedule was recommended to eliminate vapp. (7) all children should receive four doses of ipv at ages 2, 4, 6 to 18 months, and 4 to 6 years. opv is no longer available in the us and is not recommended for routine immunization. (7) previous clinical poliomyelitis (usually due to only a single poliovirus type) or incomplete immunization with opv are not contraindications to completing the primary series of immunization with ipol vaccine. children of all ages should have their immuni
havrix monodose vaccine, hepatitis a vaccine (inactivated, adsorbed) susp for inj 1440elu/ml
glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis a, virus, inactivated, elisa - suspension for injection in pre-filled syringe - hepatitis a virus (inactivated) 1440 elisa unit/dose - vaccines